Elsevier

Annals of Oncology

Volume 29, Supplement 8, October 2018, Page viii713
Annals of Oncology

Late-breaking and deferred publication abstracts
Developmental therapeutics
LBA17 - Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

https://doi.org/10.1093/annonc/mdy424.017Get rights and content
Under an Elsevier user license
open archive

Cited by (0)